Altium Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Altium Wealth Management's GILD Position: Q1 2022 in Review
Altium Wealth Management sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 3,538 shares — an estimated $257K sold.
Altium Wealth Management first reported a position in GILD in Q1 2018 and held it in 16 quarters. The position peaked at $925K in Q2 2020. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.
- Altium Wealth Management reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
- Altium Wealth Management sold 3,538 Gilead Sciences shares in Q1 2022, an estimated $257K.
- Altium Wealth Management first reported a position in Gilead Sciences in Q1 2018 and held it in 16 quarters.
- Altium Wealth Management's Gilead Sciences position peaked at $925K in Q2 2020.
- 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.
Based on Altium Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.